NANEXA.ST
Price:
$3.055
Market Cap:
$484.76M
Nanexa AB (publ) operates as a nanotechnology drug delivery company. It operates PharmaShell, a nanobased drug delivery platform that is an atomic layer deposition. The company also develops NEX-18, which drives the development of a PharmaShell that targets myelodysplastic Syndrome and Acute Myeloid Leukemia. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2015-06-17
Stock Exchange
STO
Ticker
NANEXA.ST
According to Nanexa AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is -11.75. This represents a change of 48.34% compared to the average of -7.92 of the last 4 quarters.
The mean historical PE Ratio of Nanexa AB (publ) over the last ten years is -7.93. The current -11.75 PE Ratio has changed 14.72% with respect to the historical average. Over the past ten years (40 quarters), NANEXA.ST's PE Ratio was at its highest in in the December 2023 quarter at -0.59. The PE Ratio was at its lowest in in the September 2019 quarter at -19.89.
Average
-7.93
Median
-8.88
Minimum
-12.73
Maximum
-1.13
Discovering the peaks and valleys of Nanexa AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 942.07%
Maximum Annual PE Ratio = -1.13
Minimum Annual Increase = -65.94%
Minimum Annual PE Ratio = -12.73
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -11.77 | 942.07% |
| 2023 | -1.13 | -52.89% |
| 2022 | -2.40 | -39.45% |
| 2021 | -3.96 | -63.53% |
| 2020 | -10.86 | -14.73% |
| 2019 | -12.73 | 36.83% |
| 2018 | -9.31 | 47.16% |
| 2017 | -6.32 | -25.17% |
| 2016 | -8.45 | -31.74% |
| 2015 | -12.38 | -65.94% |
The current PE Ratio of Nanexa AB (publ) (NANEXA.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-5.10
5-year avg
-6.02
10-year avg
-7.93
Nanexa AB (publ)’s PE Ratio is less than AlzeCure Pharma AB (publ) (-6.20), less than Xintela AB (publ) (-4.20), less than Acarix AB (publ) (-6.73), greater than Elicera Therapeutics AB (publ) (-21.88), less than Enorama Pharma AB (publ) (-1.97), less than Moberg Pharma AB (publ) (-1.64), greater than Promimic AB (publ) (-26.17), greater than Boule Diagnostics AB (publ) (-27.39), less than Mentice AB (publ) (-8.39), less than Physitrack PLC (-3.15),
| Company | PE Ratio | Market cap |
|---|---|---|
| -6.20 | $252.81M | |
| -4.20 | $178.65M | |
| -6.73 | $348.35M | |
| -21.88 | $285.39M | |
| -1.97 | $150.67M | |
| -1.64 | $422.77M | |
| -26.17 | $317.39M | |
| -27.39 | $202.71M | |
| -8.39 | $371.41M | |
| -3.15 | $221.15M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nanexa AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nanexa AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Nanexa AB (publ)'s PE Ratio?
How is the PE Ratio calculated for Nanexa AB (publ) (NANEXA.ST)?
What is the highest PE Ratio for Nanexa AB (publ) (NANEXA.ST)?
What is the 3-year average PE Ratio for Nanexa AB (publ) (NANEXA.ST)?
What is the 5-year average PE Ratio for Nanexa AB (publ) (NANEXA.ST)?
How does the current PE Ratio for Nanexa AB (publ) (NANEXA.ST) compare to its historical average?